Predictive Value of CA-125 for Endometriosis Staging at a Tertiary Hospital in Indonesia
DOI:
https://doi.org/10.21776/ub.jkb.2025.033.03.1Keywords:
CA-125, endometriosis, tumor markerAbstract
Endometriosis, affecting around 176 million women globally, is typically diagnosed through invasive laparoscopic inspection and histological confirmation. Due to the invasiveness of this method, noninvasive diagnostic alternatives like serum CA-125 assays are gaining interest. This study aims to determine the correlation between the tumor marker CA-125 and the stages of endometriosis, as classified by the revised American Society for Reproductive Medicine (rASRM) score. Data were retrospectively collected from the medical records of 24 reproductive-age women diagnosed with endometriosis at Dr. Moewardi General Hospital in Surakarta City, Indonesia. The dataset included patient age, serum CA-125 levels, rASRM scores, comorbidities, and surgical history. Statistical analysis involved the use of Pearson Chi-Square tests for nominal variables and independent t-tests or Mann-Whitney U-tests for scaled variables to evaluate the association between endometriosis stages (grouped into Stage I-II and Stage III-IV) and CA-125 levels (categorized as normal or elevated). A significant correlation was observed between higher stages of endometriosis (stage III-IV) and elevated CA-125 levels (p=0.040). Additionally, normal CA-125 levels were significantly associated with lower stages of endometriosis (stage I-II) (p=0.046). Furthermore, an association was found between type 2 diabetes and elevated CA-125 levels (p=0.037). In conclusion, our study suggests that elevated CA-125 levels correlate with higher stages of endometriosis (stage III-IV) and type 2 diabetes, indicating its potential as a biomarker for endometriosis severity.
Downloads
References
1. Signorile PG, Cassano M, Viceconte R, Spyrou M, Marcattilj V, and Baldi A. Endometriosis: A Retrospective Analysis on Diagnostic Data in a Cohort of 4, 401 Patients. In Vivo. 2022; 36(1): 430–438.
2. Smolarz B, Szyłło K, and Romanowicz H. Endometriosis: Epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). International Journal of Molecular Sciences. 2021; 22(19): 1-29.
3. Thatikonda R, Palve T, Shaikh S, Bulchandnani P, Kulkarni S, and Devnikar K. Clinical Features of Endometriosis: A Review of Literature. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2022; 12(1): 139.
4. Zondervan KT, Becker CM, and Missmer SA. Endometriosis. The New England Journal of Medicine. 2020; 382(13): 1244–1256.
5. Rahmawati DS. Gambaran Karakteristik dan Pencarian Pelayanan Kesehatan pada Penderita Endometriosis di Klinik Fertilitas Graha Amerta RSUD DR. Soetomo Surabaya. [Thesis]. Universitas Airlangga, Surabaya. 2019.
6. Missmer SA, Tu FF, Agarwal SK, et al. Impact of Endometriosis on Life-Course Potential: A Narrative Review. International Journal of General Medicine. 2021; 14: 9–25.
7. Becker CM, Bokor A, Heikinheimo O, et al. ESHRE Guideline: Endometriosis. Human Reproduction Open. 2022; 2022(2): 1-26.
8. Herranz-Blanco B, Daoud E, Viganò P, García-Velasco JA, and Colli E. Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers And Clinical Variables. Biomolecules. 2023; 13(7): 1-12.
9. Agarwal SK, Chapron C, Giudice LC, et al. Clinical Diagnosis of Endometriosis: A Call to Action. American Journal of Obstetrics and Gynecology. 2019; 220(4): 354.e1-354.e12.
10. Ahn SH, Singh V, and Tayade C. Biomarkers in Endometriosis: Challenges and Opportunities. Fertility and Sterility. 2017; 107(3): 523–532.
11. Irungu S, Mavrelos D, Worthington J, Blyuss O, Saridogan E, and Timms JF. Discovery of Non-Invasive Biomarkers for the Diagnosis of Endometriosis. Clinical Proteomics. 2019; 16(1): 1-16.
12. Chen Y, Pan M, Zuo Y, Yang B, and Wang S. Research Progress of CA125 in Endometriosis: Teaching an Old Dog New Tricks. Gynecology and Obstetrics Clinical Medicine. 2022; 2(4): 191–198.
13. Micu R, Gaia-Oltean AMI, Budişan L, Braicu C, Irimie A, and Berindan-Neagoe I. The Added Value of CA125, HE4, and CA72-4 as Markers for Ovarian Endometriosis Diagnosis. Romanian Journal of Morphology and Embryology. 2023; 64(2): 159–164.
14. Yorganci A, Kadioğlu N, Gümgümcü H, Özyer Ş, and Engin-Ustun Y. Serum Prolactin And CA 125 Levels in Uterine Adenomyosis. Journal of Endometriosis and Pelvic Pain Disorders. 2020; 12(3–4): 165–169.
15. Oliveira MAP, Raymundo TS, Soares LC, Pereira TRD, and Demôro AVE. How to Use CA-125 More Effectively in the Diagnosis of Deep Endometriosis. BioMed Research International. 2017; 2017: 1–6.
16. Magalhães JS, Jammal MP, Crispim PCA, Murta EFC, and Nomelini RS. Role of Biomarkers CA-125, CA-15.3 and CA-19.9 in the Distinction between Endometriomas and Ovarian Neoplasms. Biomarkers. 2021; 26(3): 268–274.
17. Tas M. The Value of the Neutrophil to Lymphocyte Ratio, Platelet to Lymphocyte Ratio and Ca-125 in Differential Diagnosis of Ovarian Endometriosis. Medicine Science International Medical Journal. 2019; 8(4): 782-785.
18. Hirsch M, Duffy J, Davis CJ, Nieves Plana M, and Khan KS. Diagnostic Accuracy of Cancer Antigen 125 for Endometriosis: A Systematic Review and Meta‐analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2016; 123(11): 1761–1768.
19. Karimi-Zarchi M, Dehshiri-Zadeh N, Sekhavat L, and Nosouhi F. Correlation of CA-125 Serum Level and Clinico-Pathological Characteristic of Patients with Endometriosis. International Journal of Reproductive BioMedicine. 2016; 14(11): 713–718.
20. Haas D, Shebl O, Shamiyeh A, and Oppelt P. The rASRM Score and the Enzian Classification for Endometriosis: Their Strengths and Weaknesses. Acta Obstetricia et Gynecologica Scandinavica. 2013; 92(1): 3–7.
21. Yu H, Li B, Li T, Zhang S, and Lin X. Combination of Noninvasive Methods in Diagnosis of Infertile Women with Minimal or Mild Endometriosis, a Retrospective Study in China. Medicine. 2019; 98(31): 1-7.
22. Tang T, Lai H, Huang X, Gu L, and Shi H. Application of Serum Markers in Diagnosis and Staging of Ovarian Endometriosis. Journal of Obstetrics and Gynaecology Research. 2021; 47(4): 1441–1450.
23. Baek JC, Jo JY, Lee SM, et al. Differences in 25-Hydroxy Vitamin D and Vitamin D-Binding Protein Concentrations According to the Severity of Endometriosis. Clinical and Experimental Reproductive Medicine. 2019; 46(3): 125–131.
24. Esteghamati A, Seyedahmadinejad S, Zandieh A, et al. The Inverse Relation of CA-125 to Diabetes, Metabolic Syndrome, and Associated Clinical Variables. Metabolic Syndrome and Related Disorders. 2013; 11(4): 256–261.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Jurnal Kedokteran Brawijaya
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
